Twice‐daily therapeutical plasma exchange‐based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French <scp>TMA</scp> Reference Center experience
Myriam Soucemarianadin(Sorbonne Université), Paul Coppo(Sorbonne Université), Agnès Veyradier(Inserm), Frédéric Pène(Centre National de la Recherche Scientifique), Y. Benhamou(Inserm), Yahsou Delmas(Centre Hospitalier Universitaire de Bordeaux), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Claire Pichereau(Centre Hospitalier Intercommunal de Poissy), Jean‐Marc Thouret(Centre Hospitalier Métropole Savoie), Éric Maury(Sorbonne Université), Claire Presne(Sorbonne Université)
Cited by 28
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|The Lancet Respiratory Medicine|2020|477
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
|Intensive Care Medicine|2017|318